Clinical Trial Update: A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating elafibranor in adult Japanese participants with Primary Biliary Cholangitis; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Elafibranor

Snippet

Sponsor: Ipsen | Conditions: Primary Biliary Cholangitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING